ArticleCancers2020

Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization.

Naoshi Odagiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.